Medical Aesthetics Market by Product (Aesthetic Implant, Body Contouring Device, Facial Aesthetic Product), Treatment (Anti-Aging & Wrinkles, Body Shaping & Cellulite, Breast Enhancement), Operation, Function, End-User - Global Forecast 2024-2030
Medical Aesthetics Market by Product (Aesthetic Implant, Body Contouring Device, Facial Aesthetic Product), Treatment (Anti-Aging & Wrinkles, Body Shaping & Cellulite, Breast Enhancement), Operation, Function, End-User - Global Forecast 2024-2030
The Medical Aesthetics Market size was estimated at USD 16.00 billion in 2023 and expected to reach USD 17.65 billion in 2024, at a CAGR 10.71% to reach USD 32.65 billion by 2030.
Medical aesthetics is a rapidly evolving field that combines healthcare and beauty services with the objective of enhancing an individual's physical appearance. These procedures target various cosmetic concerns, such as skin rejuvenation, body contouring, hair removal, facial treatments, and scar removal. Increasing awareness about cosmetic procedures due to social media platforms and celebrity endorsements has fueled demand for these treatments. Advancements in technology have resulted in safer and more effective aesthetic solutions with shorter recovery times and reduced side effects. However, the lack of standardized regulations across different regions poses challenges for the market, as it can lead to varying levels of safety and efficacy. Market players are working on developing quality procedures at cost-effective prices to stay ahead in the industry. They are exploring applications of artificial intelligence (AI) and machine learning algorithms to improve treatment planning, diagnostics, and patient engagement through personalized consultations. Increasing adoption of telemedicine consultations by healthcare providers within the medical aesthetics space has allowed patients easier access to consultation services remotely while also enabling providers with a broader reach beyond geographical boundaries.
Regional Insights
The Americas is at the forefront of innovation in the medical aesthetics market, owing to the high-income customer base and strong investments in research and development of new procedures. The U.S. FDA's strict regulations ensure that only safe and effective products enter the market, resulting in products from the region having higher consumer confidence. Moreover, North America has a mature market status with well-established players dominating the landscape. The Asia-Pacific region has experienced exponential growth due to increased disposable income levels coupled with heightened beauty consciousness among consumers. Countries such as South Korea, Thailand, and Japan have emerged as major hubs for plastic surgery tourism. Innovations like non-surgical thread lifts or energy-based devices are gaining traction among Asian consumers who prioritize natural-looking results over more invasive procedures. Europe is a key player in the global medical aesthetics industry and has a diverse market landscape with a mix of long-standing European companies and leading American brands. The market is expected to grow as consumer demand increases for minimally invasive cosmetic treatments that offer shorter recovery times and fewer side effects.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Medical Aesthetics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Growing adoption of minimally invasive and noninvasive aesthetic procedures
Rising adoption among geriatric individuals and increasing aesthetic treatments among men
Rising incidences of skin diseases and increasing expenditure on cosmetic
Market Restraints
Availability of alternative beauty and cosmetic products
Social and cultural barriers in certain emerging economies
Market Opportunities
Growing adoption of aesthetic devices for home use due to development of low cost devices
Rising medical tourism
Potential in middle class population owing to increasing disposable income
Market Challenges
Associated clinical risk and medical complications
High cost associated with the treatment and lack of reimbursement policies
Market Segmentation Analysis
Type: Increasing preference for non-surgical procedures with easy provision of products
End-User: Rising popularity of clinics and medical spas to offer an advanced aesthetics treatment
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Medical Aesthetics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Medical Aesthetics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
ExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic Brand
ExoCoBio, an exosome-based regenerative aesthetics company, acquired majority ownership in BENEV, a medical aesthetic company based in the U.S. This acquisition is expected to contribute significantly to ExoCoBio's business expansion and will serve as a bridge between exosome science and clinical application, further solidifying exosome technology as a mega-trend in the market.
Medica Forte introduces a new medium-depth chemical peel
Medica Forte, an aesthetic medical supplier, launched The Perfect Peel Superblend, a medium-depth chemical peel specifically designed for experienced medical professionals who have completed training with Medica Forte. The peel contains a powerful combination of ingredients, including glutathione and kojic acid, TCA, retinol, vitamin C, salicylic acid, resorcinol, mandelic acid, lactic acid, and azelaic acid. Its main goal is to improve skin tone and texture while stimulating collagen production.
PE firm Kedaara Capital acquires majority stake in derma chain Oliva Skin & Hair Clinic for $65 million
Kedaara Capital has acquired a majority stake in Oliva Skin & Hair Clinic, a provider of medico-aesthetic dermatology services in the field of medical aesthetics. This investment solidifies Kedaara's dedication to the advancement of the healthcare sector and the development of innovative solutions in dermatology. Together, Kedaara and Oliva are poised to revolutionize the medico-aesthetic landscape in India.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Medical Aesthetics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Medical Aesthetics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AbbVie Inc., Acumed, LLC by Colson Medical, LLC, Alma Lasers, Ltd., Alpha Aesthetics, Inc., Anika Therapeutics, Inc., Anthony Products Inc., Arion Laboratories, Avinent Implant System, S.L.U., Candela Corporation, Cutera, Inc., Cynosure, LLC, Galderma S.A., GC Aesthetics PLC, Groupe Sebbin SAS, Guangzhou Wanhe Plastic Material Co., Ltd., Hanson Medical, Inc., Implantech Associates Inc., Institut Straumann AG, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KLS Martin Group, Lattice Medical SAS, Medytox, Inc., Merz Aesthetics, Inc., Nobel Biocare Services AG, Quanta System by El.En. S.P.A., Sientra, Inc., Solta Medical International, Inc. by Bosch Healthcare Solutions GmbH, Stryker Corporation, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
This research report categorizes the Medical Aesthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Aesthetic Implant
Body Contouring Device
Facial Aesthetic Product
Hair Removal Device
Nail Treatment Laser Device
Skin Aesthetic Device
Tattoo Removal Device
Thread Lift Product
Treatment
Anti-Aging & Wrinkles
Body Shaping & Cellulite
Breast Enhancement
Facial & Skin Rejuvenation
Pigment Lesions
Psoriasis
Reconstructive
Sears
Tattoo Removal
Vascular Lesions
Vitiligo
Operation
Non-Surgical
Surgical
Function
Cellulite & Fat Reduction
Chemical Peel
Dermal Filler
Laser
Liposuction Machine
Needling
Skin Tightening & Resurfacing
End-User
Dermatology & Cosmetic Center
Hospital & Clinic
Medical Spa & Beauty Center
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of minimally invasive and noninvasive aesthetic procedures
5.1.1.2. Rising adoption among geriatric individuals and increasing aesthetic treatments among men
5.1.1.3. Rising incidences of skin diseases and increasing expenditure on cosmetic
5.1.2. Restraints
5.1.2.1. Availability of alternative beauty and cosmetic products
5.1.2.2. Social and cultural barriers in certain emerging economies
5.1.3. Opportunities
5.1.3.1. Growing adoption of aesthetic devices for home use due to development of low cost devices
5.1.3.2. Rising medical tourism
5.1.3.3. Potential in middle class population owing to increasing disposable income
5.1.4. Challenges
5.1.4.1. Associated clinical risk and medical complications
5.1.4.2. High cost associated with the treatment and lack of reimbursement policies
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing preference for non-surgical procedures with easy provision of products
5.2.2. End-User: Rising popularity of clinics and medical spas to offer an advanced aesthetics treatment
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Medical Aesthetics Market, by Product
6.1. Introduction
6.2. Aesthetic Implant
6.3. Body Contouring Device
6.4. Facial Aesthetic Product
6.5. Hair Removal Device
6.6. Nail Treatment Laser Device
6.7. Skin Aesthetic Device
6.8. Tattoo Removal Device
6.9. Thread Lift Product
7. Medical Aesthetics Market, by Treatment
7.1. Introduction
7.2. Anti-Aging & Wrinkles
7.3. Body Shaping & Cellulite
7.4. Breast Enhancement
7.5. Facial & Skin Rejuvenation
7.6. Pigment Lesions
7.7. Psoriasis
7.8. Reconstructive
7.9. Sears
7.10. Tattoo Removal
7.11. Vascular Lesions
7.12. Vitiligo
8. Medical Aesthetics Market, by Operation
8.1. Introduction
8.2. Non-Surgical
8.3. Surgical
9. Medical Aesthetics Market, by Function
9.1. Introduction
9.2. Cellulite & Fat Reduction
9.3. Chemical Peel
9.4. Dermal Filler
9.5. Laser
9.6. Liposuction Machine
9.7. Needling
9.8. Skin Tightening & Resurfacing
10. Medical Aesthetics Market, by End-User
10.1. Introduction
10.2. Dermatology & Cosmetic Center
10.3. Hospital & Clinic
10.4. Medical Spa & Beauty Center
11. Americas Medical Aesthetics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Medical Aesthetics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Medical Aesthetics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. ExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic Brand
14.3.2. Medica Forte introduces a new medium-depth chemical peel
14.3.3. PE firm Kedaara Capital acquires majority stake in derma chain Oliva Skin & Hair Clinic for $65 million